Resultado da Busca
Bert Vogelstein (born 1949) is director of the Ludwig Center, Clayton Professor of Oncology and Pathology and a Howard Hughes Medical Institute investigator at The Johns Hopkins Medical School and Sidney Kimmel Comprehensive Cancer Center.
Professor of Oncology. Background. Bert Vogelstein, M.D., was the first scientist to elucidate the molecular basis of a common human cancer. In particular, he and his colleagues have demonstrated that colorectal tumors result from the gradual accumulation of genetic alterations in specific oncogenes and tumor suppressor genes.
Year. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. AP Feinberg, B Vogelstein. Analytical biochemistry 132 (1), 6-13. , 1983. 31249. 1983. A genetic model for colorectal tumorigenesis. ER Fearon, B Vogelstein.
Bert Vogelstein is a renowned cancer researcher and a member of the National Academy of Sciences. He studies the genetics and immunotherapy of human cancer, and develops molecular genetic technologies for early detection and treatment.
- vogelbe@jhmi.edu
- 410-955-8878
- 410-955-0548
- Clayton Professor
2 de mai. de 2024 · Bert Vogelstein (born June 2, 1949, Baltimore, Md., U.S.) is an American oncologist known for his groundbreaking work on the genetics of cancer. Vogelstein was raised in Baltimore and attended a private middle school from which he was often truant, preferring to teach himself by reading at the public library.
- The Editors of Encyclopaedia Britannica
Dr. Vogelstein is a cancer researcher and co-director of the Ludwig Center at Johns Hopkins University. He studies the molecular genetics of human cancer and develops new prevention and treatment strategies based on cancer driver genes.
17 de dez. de 2021 · Learn about the life and achievements of Bert Vogelstein, M.D., the co-director of the Ludwig Center at Johns Hopkins Kimmel Cancer Center and a Howard Hughes Medical Institute investigator. He is best known for his landmark work in deciphering and explaining the molecular genetic basis of cancer.
